Sulis Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 44445832
Ole Maaløes Vej 3, 2200 København N
Income statement (kEUR)
2023 | 2024 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | -2.01 | - 167.14 |
| Employee benefit expenses | -27.84 | |
| Total depreciation | -2.53 | -30.33 |
| EBIT | -4.54 | - 225.31 |
| Other financial income | 0.03 | |
| Other financial expenses | -10.72 | |
| Pre-tax profit | -4.54 | - 236.00 |
| Income taxes | 33.69 | |
| Net earnings | -4.54 | - 202.31 |
Assets (kEUR)
2023 | 2024 | |
|---|---|---|
| Intangible rights | 149.10 | 118.77 |
| Intangible assets total | 149.10 | 118.77 |
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Inventories total | ||
| Prepayments and accrued income | 2.97 | |
| Current other receivables | 37.91 | 10.79 |
| Current deferred tax assets | 33.69 | |
| Short term receivables total | 37.91 | 47.45 |
| Cash and bank deposits | 9.39 | 367.20 |
| Cash and cash equivalents | 9.39 | 367.20 |
| Balance sheet total (assets) | 196.39 | 533.42 |
Equity and liabilities (kEUR)
2023 | 2024 | |
|---|---|---|
| Share capital | 13.42 | 13.42 |
| Retained earnings | 147.60 | 143.06 |
| Profit of the financial year | -4.54 | - 202.31 |
| Shareholders equity total | 156.48 | -45.84 |
| Non-current loans from credit institutions | 546.50 | |
| Non-current liabilities total | 546.50 | |
| Current trade creditors | 39.92 | 28.47 |
| Other non-interest bearing current liabilities | 4.29 | |
| Current liabilities total | 39.92 | 32.76 |
| Balance sheet total (liabilities) | 196.39 | 533.42 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.